← Back to Patent Explorer
US4533663A Expired / Lapsed US ⏱️ 0.0 years remaining

Quino-benzothiazine antibacterial compounds

Assignee: Abbott Laboratories
•
Filing: 1984-04-26
•
Granted: 1985-08-06
•
Expires: 2004-04-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Quino-benzothiazine compounds having the formula ##STR1## wherein R 2 is one or more constituents; R 1 is a hydrogen or a carboxy-protecting group; and Z is an amine group or an aliphatic heterocyclic group. The compounds have antibacterial activity.

Inventors

  • 👤 Daniel T. Chu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 20:13
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/06; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 337 words
A compound having the formula ##STR43## wherein R 1 is hydrogen or a carboxy protecting group; R 2 is one or more groups selected from the group consisting of hydrogen, halogen, nitro, carboxyl, methylenedioxy, cyano, C 1 to C 6 alkyl halo-substituted C 1 to C 6 alkyl, hydroxy-substituted C 1 to C 6 alkyl, a group having the formula: --Y--R.sub.3 wherein --Y-- is --O-- or --S-- and R 3 is hydrogen or C 1 to C 6 alkyl, and an amine group having the formula: ##STR44## wherein R 4 and R 5 are independently hydrogen or C 1 to C 6 alkyl; and Z is selected from the group consisting of an aliphatic heterocyclic ring having the structure ##STR45## wherein R 8 is methylene, dimethylene or a group of the formula --CH 2 --CH 2 --R 9 --CH 2 or --CH 2 --R 9 --CH 2 -- wherein R 9 is selected from the group consisting of --S--, --O-- and --N--; substituted derivatives thereof having one or more substitutents selected from the group consisting of C 1 to C 6 alkyl, C 1 to C 6 hydroxyalkyl, hydroxy, alkanoyl contaning 1 to 6 carbon atoms, alkanoylamido containing 1 to 6 carbon atoms and an amine of the formula ##STR46## wherein R 10 and R 11 are each independently selected from the group consisting of hydrogen, C 1 to C 6 alkyl, halo-substituted C 1 to C 6 alkyl and hydroxy-substituted C 1 to C 6 alkyl; and an amino group of the formula ##STR47## wherein R 6 is hydrogen or C 1 to C 10 alkyl, halo-substituted C 1 to C 10 alkyl or hydroxy-substituted C 1 to C 10 alkyl; and R 7 is selected from the group consisting of C 1 to C 10 alkyl, halo-substituted C 1 to C 10 alkyl, hydroxy-substituted C 1 to C 10 alkyl, an amine group, a mono-(C 1 to C 6 )alkylamino group and a di-(C 1 to C 6 )alkylamino group, and pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 337 words
A compound having the formula ##STR43## wherein R 1 is hydrogen or a carboxy protecting group; R 2 is one or more groups selected from the group consisting of hydrogen, halogen, nitro, carboxyl, methylenedioxy, cyano, C 1 to C 6 alkyl halo-substituted C 1 to C 6 alkyl, hydroxy-substituted C 1 to C 6 alkyl, a group having the formula: --Y--R.sub.3 wherein --Y-- is --O-- or --S-- and R 3 is hydrogen or C 1 to C 6 alkyl, and an amine group having the formula: ##STR44## wherein R 4 and R 5 are independently hydrogen or C 1 to C 6 alkyl; and Z is selected from the group consisting of an aliphatic heterocyclic ring having the structure ##STR45## wherein R 8 is methylene, dimethylene or a group of the formula --CH 2 --CH 2 --R 9 --CH 2 or --CH 2 --R 9 --CH 2 -- wherein R 9 is selected from the group consisting of --S--, --O-- and --N--; substituted derivatives thereof having one or more substitutents selected from the group consisting of C 1 to C 6 alkyl, C 1 to C 6 hydroxyalkyl, hydroxy, alkanoyl contaning 1 to 6 carbon atoms, alkanoylamido containing 1 to 6 carbon atoms and an amine of the formula ##STR46## wherein R 10 and R 11 are each independently selected from the group consisting of hydrogen, C 1 to C 6 alkyl, halo-substituted C 1 to C 6 alkyl and hydroxy-substituted C 1 to C 6 alkyl; and an amino group of the formula ##STR47## wherein R 6 is hydrogen or C 1 to C 10 alkyl, halo-substituted C 1 to C 10 alkyl or hydroxy-substituted C 1 to C 10 alkyl; and R 7 is selected from the group consisting of C 1 to C 10 alkyl, halo-substituted C 1 to C 10 alkyl, hydroxy-substituted C 1 to C 10 alkyl, an amine group, a mono-(C 1 to C 6 )alkylamino group and a di-(C 1 to C 6 )alkylamino group, and pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 34 words
A compound as defined in claim 1 wherein the aliphatic heterocyclic ring is selected from the group consisting of azetidinyl groups, piperazinyl groups, piperidinyl groups, pyrrolidinyl groups, morpholino groups, thiomorpholino groups and homopiperazinyl groups.
Claim 4
Dependent Claim 12 words
A compound as defined in claim 1 wherein R 1 is hydrogen.
Claim 5
Dependent Claim 84 words
A compound as defined in claim 1 wherein Z is an amino group having the formula: ##STR48## wherein R 6 is hydrogen, C 1 -C 10 alkyl, halo-substituted C 1 to C 10 alkyl, or hydroxy-substituted C 1 to C 10 alkyl, and R 7 is C 1 -C 10 alkyl, halo-substituted C 1 to C 10 alkyl, or hydroxy-substituted C 1 to C 10 alkyl, an amino group, a mono-(C 1 -C 4 )alkylamino group or a di(C 1 -C 4 )-alkylamino group.
Claim 6
Dependent Claim 59 words
A compound having the formula: ##STR49## wherein Z is piperazinyl or piperazinyl substituted with a C 1 to C 6 alkyl, or 4-acylpiperazinyl, or 3-amino-pyrrolidinyl or 3-C 1 to C 6 alkylamino-pyrrolidinyl; and R 2 is one or more of hydrogen, an alkyl group, a halogen group, a hydroxy group, and a methylenedioxy group, and pharmaceutically acceptable salts thereof.
Claim 7
Dependent Claim 59 words
A compound having the formula: ##STR49## wherein Z is piperazinyl or piperazinyl substituted with a C 1 to C 6 alkyl, or 4-acylpiperazinyl, or 3-amino-pyrrolidinyl or 3-C 1 to C 6 alkylamino-pyrrolidinyl; and R 2 is one or more of hydrogen, an alkyl group, a halogen group, a hydroxy group, and a methylenedioxy group, and pharmaceutically acceptable salts thereof.
Claim 8
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is hydrogen, Z is piperazinyl and R 1 is hydrogen.
Claim 9
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is hydrogen, Z is 4-methylpiperazinyl and R 1 is hydrogen.
Claim 10
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 10-fluoro, Z is piperazinyl and R 1 is hydrogen.
Claim 11
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 10-fluoro, Z is 4-methylpiperazinyl and R 1 is hydrogen.
Claim 12
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is hydrogen, Z is 3-aminopyrrolidinyl and R 1 is hydrogen.
Claim 13
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 10-fluoro, Z is 3-aminopyrrolidinyl and R 1 is hydrogen.
Claim 14
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is hydrogen, Z is 3-methylaminopyrrolidinyl and R 1 is hydrogen.
Claim 15
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 10-fluoro, Z is 3-dimethylaminopyrrolidinyl and R 1 is hydrogen.
Claim 16
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 10-hydroxy, Z is piperazinyl and R 1 is hydrogen.
Claim 17
Dependent Claim 20 words
A compound as defined in claim 5 wherein R 2 is 8,10-difluoro, Z is 4-methylpiperazinyl and R 1 is hydrogen.
Claim 18
Dependent Claim 20 words
A composition having antibacterial activity in pharmaceutical dosage form containing a diluent and a compound as defined in claim 1.
Claim 19
Dependent Claim 32 words
A method of treating a bacterial infection in a patient comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound as defined in claim 1.

References Cited (Backward Citations)

US3052678A Cited
US2919271A Cited
US3294790A Cited
GB1147336A Cited
US3493567A Cited
US3525743A Cited
US4017622A Cited
US3962438A Cited
US4292317A Cited
US4382892A Cited
EP0078362A2 Cited
US4443447A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-08-05 1989-02-04 1989-08-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-08-05 1993-02-04 1993-08-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-08-05 1997-02-04 1997-08-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag